Genelux Corporation AND _____________, AS WARRANT AGENT FORM OF PREFERRED STOCK WARRANT AGREEMENT DATED AS OF __________ GENELUX CORPORATION FORM OF PREFERRED STOCK WARRANT AGREEMENTWarrant Agreement • February 2nd, 2024 • GENELUX Corp • Pharmaceutical preparations • New York
THIS PREFERRED STOCK WARRANT AGREEMENT (this “Agreement”), dated as of [●], between Genelux Corporation, a Delaware corporation (the “Company”), and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).
Genelux Corporation Shares of Common Stock ($0.001 par value per share) SALES AGREEMENTSales Agreement • February 2nd, 2024 • GENELUX Corp • Pharmaceutical preparations • New York
Genelux Corporation, a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Guggenheim Securities, LLC (the “Agent”), as follows:
GENELUX CORPORATION AND _____________, AS WARRANT AGENT FORM OF DEBT SECURITIES WARRANT AGREEMENT DATED AS OF __________ GENELUX CORPORATION FORM OF DEBT SECURITIES WARRANT AGREEMENTWarrant Agreement • February 2nd, 2024 • GENELUX Corp • Pharmaceutical preparations • New York
THIS DEBT SECURITIES WARRANT AGREEMENT (this “Agreement”), dated as of [●], between GENELUX CORPORATION, a Delaware corporation (the “Company”), and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).
